Clinical Trial Update: Study of MRA for Polyarticular Juvenile Idiopathic Arthritis (pJIA) [Phase 3]

View source ↗

Summary

Phase 3 clinical trial evaluating MRA for polyarticular juvenile idiopathic arthritis has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Polyarticular Juvenile Idiopathic Arthritis
• Systemic Juvenile Idiopathic Arthritis

Drugs mentioned

• MRA (MRA)

Snippet

Sponsor: Chugai Pharmaceutical | Conditions: Systemic Juvenile Idiopathic Arthritis | Phase 3 | Status: COMPLETED